Lung Cancer Considered

By IASLCScience

Lung Cancer Considered episodes

July 15, 2019 NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon
Dr. Jack West is joined by Dr. Alexander Drilon to discuss the challenge of NGS testing and increased participation and funding in lung cancer clinical trials. Dr. Drilon is Associate Attending Physician and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center in New York. Dr. Drilon has been at the forefront of development of many novel targeted therapies for some of the newest biomarker-driven therapies for advanced non-small cell.
20 min
July 06, 2019 State Of Mesothelioma Treatment With Dr. Anne Tsao
Dr. Jack West is joined by Dr. Anne Tsao for a conversation on the state of treatment of mesothelioma in anticipation of the first IASLC 2019 Mesothelioma Meeting July 10-12, 2019 in New York, NY. Dr. Tsao is Professor in the Department of Thoracic Head and Neck Medical Oncology in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston. She is also Director of the Mesothelioma Program and Director of the Thoracic Chemo Radiation program.
12 min
July 01, 2019 A Conversation With Thoracic Oncologist Dr. Corey Langer
Dr. Jack West is joined by Dr. Corey Langer to discuss lung cancer management, niche patients including PS2 and elderly patients, the evolution of small cell lung cancer treatment and care, and chemo immunotherapy. Dr. Langer is Director of Thoracic Oncology and Professor of Medicine at the Hospital of the University of Pennsylvania in Philadelphia.
27 min
June 19, 2019 Radiation Oncology And Proton Therapy, Dr. Walter J. Curran
Dr. Jack West is joined by Dr. Walter J. Curran for discussions on radiation oncology, immunotherapy and the interaction with radiation, and the evolution of proton therapy including growth of the field and access to treatment. Dr. Curran is Executive director of the Winship Cancer Institute of Emory University and current chair of the NRG Oncology Group.
18 min
June 03, 2019 Medication For Lung Cancer Treatment With Dr. David Spigel
Dr. Jack West is joined by Dr. David Spigel to discuss medication for lung cancer treatment, checkpoint inhibitor therapy and the future of duration of treatment for lung cancer patients. Dr. Spigel is Chief Scientific Officer at Sarah Cannon Research Institute in Nashville, Tennessee. Dr. Spigel is a medical oncologist with a particular focus on thoracic oncology.
21 min
May 30, 2019 IASLC President-Elect Elections: Introducing Candidate Dr. Pasi Janne
IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Pasi Janne, a translational thoracic medical oncologist at the Dana Farber Cancer Institute and Professor of Medicine at Harvard Medical School. He is also the Director of the Lowe Center for Thoracic Oncology and the Director of the Belfer Center for Applied Cancer Science. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
16 min
May 30, 2019 IASLC President-Elect Elections: Introducing Candidate Dr. Heather Wakelee
IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. Heather Wakelee, Professor of Medicine, Oncology at Stanford University in Stanford, California. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
22 min
May 30, 2019 IASLC President-Elect Elections: Introducing Candidate Dr. William Travis
IASLC CEO Dave Mesko sits down with IASLC President-Elect candidate, Dr. William Travis, Attending Thoracic Pathologist at Memorial Sloan Kettering Cancer Center in New York. Voting is available to active IASLC members and ends at 11:59 Eastern Time on June 26, 2019. Vote at directvote.net/IASLC.
20 min
May 20, 2019 Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara
Dr. Jack West is joined by Dr. David Gandara to discuss blood based testing for molecular interrogation, blood based assays for tumor mutational burden, and how the landscape of lung cancer and the IASLC have evolved. Dr. Gandara is Professor of Medicine and Senior Adviser to the Director of Medical Oncology at University of California Davis in Davis, CA and past president of the IASLC.
22 min
May 06, 2019 A Conversation With Medical Oncologist Joan Schiller
Dr. Jack West is joined by Dr. Joan Schiller to discuss new developments in the field of lung cancer, the results of the trial ECOG 1594, mentorship in oncology, and women's support and representation in the practice of lung cancer. Dr. Schiller is a medical oncologist with a focus on thoracic oncology, faculty of the University of Virginia and previous chair of the lung cancer committee for the Eastern Cooperative Oncology Group.
15 min

About Lung Cancer Considered

From the publisher's feed

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.